Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B-Cell Lymphoma Therapy
利用CD22和选择素的糖配体对NK细胞进行糖基化改造,用于B细胞淋巴瘤治疗
期刊:Angewandte Chemie-International Edition
影响因子:16.9
doi:10.1002/anie.202005934
Hong, Senlian; Yu, Chenhua; Wang, Peng; Shi, Yujie; Cao, Weiqian; Cheng, Bo; Chapla, Digantkumar G; Ma, Yuanhui; Li, Jie; Rodrigues, Emily; Narimatsu, Yoshiki; Yates, John R 3rd; Chen, Xing; Clausen, Henrik; Moremen, Kelly W; Macauley, Matthew Scott; Paulson, James C; Wu, Peng